Rick Berke

Co-founder & executive editor, STAT @statnews. Longtime reporter, editor @nytimes

[Brittany Trang @brittanytrang]

Missed out on #BIO2026, or STAT's BIO coverage? Alex Hogan has got you covered with this video recap:

https://t.co/exjRfS0Kxu

[Rick Berke @rickberke]

Newsy lay of the land from #BIO2026 in San Diego

[Daniel Payne @_daniel_payne]

Vaccine makers have had a brutal run — but some are still seeing hopeful signs in their sector

https://t.co/mkW5M1rLad

[Lizzy Lawrence @LizzyLaw_]

NEW: Democrats press White House on who got special access to Eli Lilly’s new obesity drug
https://t.co/lp6ymdTkaP

[Rick Berke @rickberke]

Congrats to @_gaffknee @UnderSecPD for being recognized for her reporting on the funding turmoil for early career trans researchers

[NLGJA: The Association of LGBTQ+ Journalists @nlgja]

🎉 We are thrilled to announce the winners of our 2026 Excellence in Journalism Awards!

These awards, begun in 1993, honor the storytellers capturing our community's joy, resilience and truth. View the full list of award winners at the link in our bio ⬆️

[Rick Berke @rickberke]

.⁦@KatieMPalmer⁩ has the rare backstory of an abandoned heart failure trial and the implications for patients https://t.co/dNWy5YUxJr

[Lizzy Lawrence @LizzyLaw_]

For @NPR, I discussed my story on Eli Lilly granting early access of obesity drug retatrutide to a 79-year-old patient in April. You can listen here: https://t.co/qJjSYodrJV

[Rick Berke @rickberke]

We’re here at #BIO2026 with reporters @brittanytrang @_daniel_payne @megkesh @HoganAlex
Find us and say hi!

[STAT @statnews]

STAT is in San Diego at the annual BIO conference!

[Rick Berke @rickberke]

The scoop that’s already the talk of worlds of health, politics, government, drug companies. How will the mystery be resolved?

[Lizzy Lawrence @LizzyLaw_]

EXCLUSIVE: Eli Lilly gave compassionate use access to retatrutide, their unapproved powerful obesity drug, to a 79-year-old man in April. The application was arranged by a top doctor at NIH, and cleared by the FDA.
https://t.co/bakw09t4D3

[Jason Ukman @JasonUkman]

New: Federal officials are seeking to speed up clinical trials, and an increasingly innovative China appears to be a not-so-small reason for the shift.

Via @ChelseaCirruzzo @LizzyLaw_

https://t.co/aDfKu8DmOM

[Matthew Herper @matthewherper]

I really, really loved being on @DKThomp 's podcast earlier this week and talking about the current wave of biotech innovation and all the way's we're not ready for it. If you pull the string on my back I say, "This is biology's century and we're not ready for it."

My family and I also really enjoyed the comments on the Spotify thread for the podcast. As my wife said: "Killing the joy with extensive knowledge since 2000."

[Daniel Payne @_daniel_payne]

After secret drug pricing deals with Trump, some drugmakers are mapping out how they could respond to Democrats' oversight efforts, should they take control of Congress.

https://t.co/BkRUtwQhNV

[STAT @statnews]

STAT is your trusted source for health policy and biotech news. A STAT+ subscription unlocks exclusive reporting and expert analysis that keeps you informed and ahead in this fast-changing field. Stay connected with the insights that matter most.

[Rick Berke @rickberke]

Bob was the trusted, authoritative voice for Robin Toner and other health reporters for decades

[julie rovner @jrovner]

😢One of my favorite people in all of health policy. RIP Bob.

[Rick Berke @rickberke]

Refreshingly upbeat conversation about possible “medical miracles” @DKThomp and @matthewherper @statnews

[Derek Thompson @DKThomp]

New pod: INSIDE THE MOST MIRACULOUS MONTH OF MEDICAL BREAKTHROUGHS IN ... YEARS? DECADES?

The two leading causes of death in America are heart disease and cancer. Nothing else comes close.

And in the last 4 weeks, we've gotten sensational news on unprecedented therapies that fight (even "cure") cardiovascular disease and take on previously "undruggable" cancers

I went deep with @matthewherper on:
- why the latest GLP1, retatrutide, works so well
- is ~everybody is going to be taking low-dose GLP1s in the next 10-20 years because of the side-effect profile?
- new evidence that GLP1s might significantly reduce some cancers
- daraxonrasib, the miraculous new pancreatic cancer vaccine, and why it seems to do the impossible
- promising, if experimental, new results for a one-and-done gene therapy to wipe out vast swaths of heart disease risk
- where is AI in all of this?

https://t.co/tiHFjfTgHw

[Nieman Lab @NiemanLab]

News sites are rapidly becoming the newspapers of the digital age. And you know what happened to newspapers.

https://t.co/4txQfNvM2z

[Isa Cueto @isabellacueto]

Horrifying: 800% increase in American babies born yearly with syphilis between 2012 and 2024.

Congenital syphilis can cause bone deformities, brain damage, blindness, deafness, or other complications.

Preventable with basic antibiotic. Via @EricBoodman:

https://t.co/iAxJyA485c

[Rick Berke @rickberke]

A nightmare. New @statnews investigation by @EricBoodman

[STAT @statnews]

Rise in adult cases and Bicillin shortage set stage for ’never event’ https://t.co/GRBITizvPH

[Rick Berke @rickberke]

.@TaraBannow looks at enormous industry — swag and all — built around paying medical bills
https://t.co/3S1tyCxJJP via @statnews

[Mick Jagger @MickJagger]

Remembering David Hockney, he was kind and always had a sparkle in his eye. He never stopped experimenting and is one of the finest painters of our generation.

[Zachary Tracer @ZTracer]

.@isabellacueto has been doing the herculean job of tracking RFK Jr.'s MAHA promises. In her latest update, she finds he still has a lengthy to-do list:

https://t.co/jE4CbreGSe